U.S. Releases Draft Guidelines for Generic Biologic Drugs – Bloomberg
While low-cost copies of biotech drugs are used in Europe, none has yet been approved in the U.S. The law requires the FDA to establish a review process for the treatments that may cut costs for public health programs like Medicare about $7 ...
Subscribe to LegalLaw247.Com Newsletter
